行情

ANAB

ANAB

AnaptysBio
NASDAQ

实时行情|Nasdaq Last Sale

44.73
-0.53
-1.17%
盘后: 44.73 0 0.00% 17:07 09/17 EDT
开盘
45.50
昨收
45.26
最高
46.34
最低
44.25
成交量
49.43万
成交额
--
52周最高
110.00
52周最低
38.53
市值
12.10亿
市盈率(TTM)
-14.9115
分时
5日
1月
3月
1年
5年

分析师评级

10位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

ANAB 新闻

  • 韩国出牌正式将日本踢出白名单 “战火”跨界延烧
  • 中国新闻网.3小时前
  • 特朗普提名的理事人选谢尔顿呼吁美联储与白宫合作
  • 新浪财经综合.3小时前
  • 沪指小幅高开 美联储十年来首次重启回购操作
  • 新浪财经.3小时前
  • 内部有分歧的美联储本周势将再度降息 但之后呢?
  • 新浪财经综合.4小时前

更多

所属板块

生物技术和医学研究
+0.24%
制药与医学研究
+0.57%

热门股票

名称
价格
涨跌幅

ANAB 简况

AnaptysBio, Inc. is a clinical-stage biotechnology company. The Company is engaged in developing antibody product candidates focused on unmet medical needs in inflammation and immuno-oncology. The Company develops its product candidates using its antibody discovery technology platform, which is designed to replicate, in vitro, the natural process of antibody generation. Its product pipeline includes ANB020 and ANB019, which are being developed to treat severe inflammatory disorders with unmet medical need. The Company's ANB020 product candidate is an antibody that inhibits the activity of interleukin-33, and is used for the treatment of severe adult asthma and severe adult peanut allergy. In addition, the Company is engaged in developing its ANB019 product candidate, an antibody that inhibits the interleukin-36 receptor, for the treatment of rare inflammatory diseases called generalized pustular psoriasis (GPP) and palmoplantar pustular psoriasis (PPP).
展开

Webull提供AnaptysBio Inc的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。